SCHEMBL10579997

SCHEMBL10579997

NC(=O)C(O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.67
▸ ADORA2B P29275 4/20 0.67
▸ ADORA3 P0DMS8 4/20 0.64
▸ TSHR P16473 3/20 0.64
▸ PMP22 Q01453 2/20 0.64
▸ ADORA1 P30542 2/20 0.64
▸ GAA P10253 1/20 0.64
▸ HTT P42858 1/20 0.64
▸ SIGMAR1 Q99720 1/20 0.64
▸ SLC29A1 Q99808 1/20 0.64
▸ RXFP1 Q9HBX9 1/20 0.64
▸ MEN1 O00255 1/20 0.64
▸ KMT2A Q03164 1/20 0.64
▸ TP53 P04637 1/20 0.64
▸ NFKB1 P19838 1/20 0.64
▸ HIF1A Q16665 1/20 0.64
▸ SMN1; SMN2 Q16637 1/20 0.63
▸ TDP1 Q9NUW8 1/20 0.63
▸ CYP2C19 P33261 1/20 0.63
▸ THPO P40225 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10580014 1.00 ADORA2A (0.67) ADORA2AADORA2BADORA3TSHRPMP22
SCHEMBL1298953 0.89 ADORA3 (0.74) ADORA2AADORA2BADORA3TSHRPMP22
SCHEMBL10579771 0.87 ADORA2A (0.62) ADORA2AADORA2BADORA3TSHRPMP22
SCHEMBL9495200 0.86 ADORA2A (0.73) ADORA2AADORA2BADORA3TSHRPMP22
SCHEMBL30139992 0.81 AHCY (0.68) ADORA2AADORA2BADORA3TSHRADORA1
SCHEMBL30139993 0.81 AHCY (0.68) ADORA2AADORA2BADORA3TSHRADORA1
SCHEMBL11884228 0.81 AHCY (0.53) ADORA2AADORA2BADORA3TSHRADORA1
SCHEMBL11884247 0.81 AHCY (0.53) ADORA2AADORA2BADORA3TSHRADORA1
SCHEMBL4520798 0.81 AHCY (0.68) ADORA2AADORA2BADORA3TSHRADORA1
SCHEMBL4520806 0.81 AHCY (0.68) ADORA2AADORA2BADORA3TSHRADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4868160-A Method of treating psychosis using N6 -substituted -5'-oxidized adenosine analogs WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4738954-A HYPOTENSIVE AGENTS, ANALGESICS, NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1988-04-19 — — US disclosed
EP-0222330-A2 N6-Substituted-5'-oxidized adenosine analogs WARNER-LAMBERT COMPANY (US) 1987-05-20 — — EP disclosed
Send feedback